Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis.
Arushi KhuranaJoanna C DallandJason R YoungDavid J InwardsJonas PaludoPublished in: American journal of hematology (2021)